Pharmaceutical Commerce

SEPTEMBER 6, 2024

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

Distribution 52

Distribution Biopharma Leads Healthcare 52

Clarivate

APRIL 24, 2023

healthcare payers and providers are consolidating at a dizzying clip as they seek to gain market share, increase access to care and secure clinical control to improve health outcomes. Payers are responding by creating, acquiring or fortifying provider networks and healthcare clinics of their own.

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

Pharmaceutical Technology

APRIL 20, 2023

CBC CEO Fu Wei stated: “Hasten is a well-established Chinese biopharma company with tremendous growth potential. Hasten will also use the proceeds from the round to fund future acquisitions. The firm reported 47% growth in sales from Q2 to Q4 in 2022, which is testament to CBC’s unique and effective investor-operator strategy.

Biopharma 98

Biopharma Healthcare Healthcare Sales 98

PM360

JULY 18, 2022

FINN Partners , an independent marketing and communications agency, is expanding its global footprint even further with the addition of SPAG , a leading, Asia-headquartered, health-sector communications and marketing firm with offices in Bangalore, Delhi, Indonesia, Malaysia, Mumbai, the Philippines, and Singapore. and Europe.

Biopharma 96

Biopharma Management Marketing Leads 96

PM360

MARCH 28, 2023

The Healthcare Businesswomen’s Association (HBA) has appointed Mary Stutts as Chief Executive Officer where she will lead the global association’s mission to accelerate the advancement and impact of women in the business of healthcare. Morgan Healthcare Conference.

Healthcare 52

Healthcare Healthcare Biopharma Leads 52

pharmaphorum

NOVEMBER 18, 2022

Biopharma’s digital interactions with healthcare professionals (HCPs) are now a critical part of industry relationships. How would you describe the current state of HCP engagement amongst biopharmas? The biggest driver of omnichannel success is meeting HCPs’ preferences for more hybrid, on-demand access to their biopharma reps.

Biopharma 98

Biopharma Leads Engineering Sales 98

Pharma Marketing Network

MARCH 30, 2023

Mary brings to the HBA 30 years of experience leading the strategic integration of corporate branding, marketing, health equity, inclusion, and digital innovation for biopharma, healthcare, and media companies. Morgan Healthcare Conference.

Healthcare 52

Healthcare Healthcare Biopharma Leads 52

PM360

SEPTEMBER 21, 2023

This “synchronization” helps biopharmas such as Pfizer maximize marketing and field efforts across their organizations to improve engagement with healthcare professionals (HCPs). However, many biopharmas fail to synchronize engagement and digital touchpoints in a timely manner for 73% of HCPs. But this change can be doable.

Marketing 105

Marketing Media CRM Sales 105

Pharmaceutical Technology

SEPTEMBER 8, 2022

The expert services rendered by them help in improving patient outcomes, minimising costs of the healthcare system, improving medicinal adherence and persistency and saving clinicians’ time. The post Leading speciality pharmacies in pharma appeared first on Pharmaceutical Technology.

Specialization 45

Specialization Leads Pharma Side effects 45

Pharma Marketing Network

JANUARY 12, 2023

FAIRFIELD, NJ (12 January, 2023) – The Healthcare Businesswomen’s Association (HBA) announces the 2023 Woman of the Year, Honorable Mentor, and STAR. The HBA Woman of the Year award honors a female senior executive whose accomplishments have resulted in significant contributions to the healthcare industry. Jag Dosanjh, President, U.S.

Healthcare 52

Healthcare Healthcare Networking Manufacturing 52

pharmaphorum

JANUARY 9, 2023

Biopharma and healthcare group Chiesi Farmaceutici S.p.A. Supported by voting agreements from leading Amryt shareholders and directors, and unanimously approved and recommended by the boards of both companies, the total transaction is worth up to $1.48 is to acquire the 2015-established Amryt Pharma Plc. on 6 th January.

Pharma 98

Pharma Biopharma Management Medicine 98

European Pharmaceutical Review

AUGUST 22, 2022

THE GLOBAL outbreak of the COVID-19 pandemic triggered an urgent need to protect people’s lives and livelihoods and the healthcare community recognised quite early that vaccines were the best solution to this crisis. The biopharma sector has witnessed significant transformations in recent times.

Manufacturing 98

Manufacturing Biopharma Engineering Safety 98

PM360

OCTOBER 8, 2024

A serial entrepreneur, executive business leader and board member, he brings more than 35 years’ experience of critical safety service and technology solution provision to biopharma R&D, Commercial and Operations functions. It was a great honor to be approached to lead Qinecsa’s next important growth phase.

Leads 52

Leads Safety Biopharma Management 52

PM360

JUNE 30, 2022

It includes companies Vynamic, Research Partnership, Putnam Associates, and STEM Healthcare. Inizio Medical: By combining complex scientific understanding with creativity, Inizio Medical promises to create compelling content and engage communities across the spectrum of healthcare.

Specialization 97

Specialization Medical Healthcare Healthcare 97

pharmaphorum

DECEMBER 23, 2022

In 2022, life sciences companies have been hard at work breaking down silos to better serve patients and healthcare professionals (HCPs). With these silos breaking down, biopharmas will have the opportunity to drive a more coordinated approach to HCP engagement using shared data and unified systems, while still maintaining compliance.

Marketing 105

Marketing Sales Medical Patients 105

pharmaphorum

JANUARY 11, 2023

Last year, digital health ventures registered a total of 575 regulatory filings around the world, with the medical diagnostics cluster – diagnostic tools, medical imaging, and omics-related analyses – leading the charge with 12% of the total. Roche tops biopharma partnering podium.

Biopharma 75

Biopharma Specialization Physicians Healthcare 75

pharmaphorum

JANUARY 6, 2023

Emerging and mid-sized companies launching products in Europe are also navigating a healthcare ecosystem that is complex and fragile due to regulatory and cost pressures. With an early view of market viability, leading companies will be able to monetise new products quickly and at scale across Europe.”.

Safety 111

Safety Management Patients Training 111

Clarivate

OCTOBER 25, 2021

This year, Clarivate acquired Bioinfogate , a leading provider of analytics solutions in the life sciences and producer of the OFF-X portal. The move further expands and integrates drug toxicity data and translational safety intelligence from OFF-X into all aspects of the life science cycle.

Safety 110

Safety Biopharma Competition Leads 110

Pharma Marketing Network

SEPTEMBER 15, 2021

15 September, 2021)—With gender inequality a continued area of focus for corporations and workplaces around the globe, the Healthcare Businesswomen’s Association (HBA) is proud to recognize Merck & Co., for exemplary workplace initiatives working to close the gender gap in the healthcare and life science industries.

Healthcare 52

Healthcare Healthcare Networking Management 52

Clarivate

JULY 31, 2023

Following the acquisition of Dialog Solutions as part of the ProQuest M&A in December 2021, Dialog Solutions products and services will be folded into the Clarivate portfolio of offerings for Life Sciences & Healthcare. To learn more about the Dialog platform, visit: here.

Healthcare 52

Healthcare Healthcare Safety Competition 52

PM360

SEPTEMBER 18, 2024

Varady has spent the last 20 years leading integrated marketing campaigns for biotech and healthcare companies in both U.S. His experience leading large-scale agency accounts for top 10 biopharma companies has led to the successful commercialization of products across a wide array of therapeutic categories.

Marketing 52

Marketing Media Healthcare Healthcare 52

pharmaphorum

OCTOBER 20, 2022

In my experience working on global biopharma brands, commercial success is built on collaboration and solid basics. Answering these questions will help you build the foundation of your commercial strategy, but, to be effective, biopharma organisations must be sure to derive the right conclusions from the analysis.

Competition 98

Competition Marketing Pharma Biopharma 98

PM360

AUGUST 24, 2023

As professionals with more than a half-century between us working in biopharma and diagnostics marketing and communications from the corporate (Ayaz Malik) and agency (Sandra Stahl) sides, we believe nurturing multigenerational teams is an especially powerful yet underutilized strategy for our industry. To be sure, steps have been taken.

Competition 98

Competition Marketing Healthcare Healthcare 98

PM360

SEPTEMBER 28, 2022

At Roche at the time, his job was to lead a task force which was given the objective of planning a strategy to preserve and protect the companies billion-dollar originator biologics franchises as well as build a plan which would counter the introduction and use of biosimilars. Now, as the President of Accord BioPharma , the U.S.

Competition 98

Competition Marketing Manufacturing Biopharma 98

Pharmaceutical Technology

MAY 5, 2023

Hasten Biopharmaceutic has purchased the commercial rights for Rocephin in mainland China from Swiss healthcare firm Roche. Hasten Biopharma CEO Summer Xia stated: “Hasten is committed to building a leading innovative medical and healthcare enterprise in China.

Biopharma 52

Biopharma Healthcare Healthcare Leads 52

pharmaphorum

SEPTEMBER 12, 2022

Dr Prasanth Reddy, head of oncology at LabCorp, tells us how the company works with cancer care teams, biopharma partners, and patients as an integral part of the patient journey from testing to treatment. Knowledge can change the course of healthcare for all and alter the course of care for individuals in need. Tailored oncology.

Patients 105

Patients Medicine FDA Healthcare 105

PM360

SEPTEMBER 15, 2022

But battling information asymmetry is one of the best ways to address the ongoing inequities in our healthcare system. But to shift the industry’s approach to healthcare, all stakeholders must move the efforts, attention, and education necessary to find a common ground and ensure that the patients’ interests are always driving development.

Patients 98

Patients Healthcare Healthcare Marketing 98

European Pharmaceutical Review

DECEMBER 21, 2022

The healthcare industry is successful in innovating new treatment paradigms ranging from small molecular to biological therapeutics to personalised medicines. Production and value creation can be regionalised and decentralised, which could lead to a more resilient economic structure. The path to real zero.

Manufacturing 97

Manufacturing Pharmaceutical Healthcare Healthcare 97

PM360

APRIL 22, 2024

In this issue, we take a closer look on the importance of patient education to Healthcare Professionals and navigating the challenges that arise. With an ever- increasing demand for their time and attention, it is more difficult than ever for biopharma representatives to convey their message to the physician audience.

Education 59

Education Physicians Healthcare Healthcare 59

pharmaphorum

SEPTEMBER 28, 2022

A step-by step guide on the benefits, processes, and key considerations involved in the Healthcare Technology Assessment (HTA) Early Scientific Advice (ESA) consultation as part of planning the holistic evidence generation to support the design of an asset. In recent years, the biopharma market has become progressively complex.

Biopharma 52

Biopharma Side effects Consulting Pharmaceutical products 52

Clarify Health

MAY 19, 2020

There is also a looming, time-sensitive reality that biopharma companies face once their products hit the market: they need to recoup the costs of development as quickly as possible before drug patents expire and generics threaten sales. sales, medical science liaisons, etc.).

Biopharma 52

Biopharma Physicians Marketing Patients 52

pharmaphorum

OCTOBER 11, 2022

Talking through their generic medicines, of which the company has more than 1,000 projects ongoing, Schultz noted that more than half of the leading medicines on the WHO’s list of medicines are Teva’s. Stating this might not be “good business”, nevertheless, increasing access to treatments was, he said, “good healthcare”.

Pharma 98

Pharma Patients Medicine Healthcare 98

European Pharmaceutical Review

FEBRUARY 21, 2023

Crucially, January 2023 marked a key moment: the Medicines and Healthcare products Regulatory Agency (MHRA) granted Celadon Pharmaceuticals the first good manufacturing practice (GMP) registration since legalisation in 2018 for high Δ9-tetrahydrocannabinol (THC) cannabis active pharmaceutical ingredient (API). He founded Celadon in 2018.

Medicine 132

Medicine Manufacturing Specialization Pharmaceutical 132

Clarivate

FEBRUARY 28, 2023

Degeneration of the retinal ganglion cells causes rapidly progressing vision loss, leading to permanent (non-painful) blindness within a year. The Incidence and Prevalence Database (IPD) , a Cortellis solution, provides information on LHON prevalence and primary mutations, morbidity and mortality rates. The Clarivate U.S. ” Cureus; V.12;

Patients 98

Patients Prescription Pharmacology Healthcare 98

Legacy MEDSearch

MAY 19, 2023

Through this collaboration, healthcare providers are able to access clinically relevant heart rhythm analyses and actionable reports via PaceMateLIVE to monitor at-risk patients; identify underlying arrhythmias, including atrial fibrillation (AF); and drive improvements to patient care and clinical outcomes.

Healthcare Provider 52

Healthcare Provider Management Healthcare Healthcare 52

Medgadget

FEBRUARY 17, 2023

Thanks to kind support from Biomed Israel , the leading international Life Science and HealthTech conference in Israel (see more below), we met with Ronan Castro, the CEO of Human Xtensions at the company’s offices in Netanya, Israel.

Physicians 80

Physicians Engineering Leads Side effects 80

PM360

JUNE 24, 2024

This fuels an enormous need for effective patient communication and education as new therapies move through the biopharma pipeline. Those of us in the biopharma industry know how fraught drug development can be. As the saying goes, they are individually rare but collectively common. Many people, cumulatively, are affected.

Marketing 52

Marketing Patients Food and Drug Administration Digital Media 52